{"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:company:halozyme-therapeutics-inc","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"protocol_version":"0.1","schema_version":"alpha.governance.entity.public.v1","record_version":"public-1","entity":{"id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","type":"Company","slug":"halozyme-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/halozyme-therapeutics-inc","legal_name":"HALOZYME THERAPEUTICS, INC.","display_name":"HALOZYME THERAPEUTICS, INC.","aliases":[]},"publication":{"state":"PUBLISHED","published_at":"2026-10-05T15:31:01.100054+00:00","observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":"2026-10-05T15:31:01.100054+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":16,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/halozyme-therapeutics-inc","media_type":"text/html"},"markdown":{"href":"https://registry.alpha.ac/companies/halozyme-therapeutics-inc.md","media_type":"text/markdown"},"json":{"href":"https://registry.alpha.ac/api/public/companies/halozyme-therapeutics-inc?format=record","media_type":"application/json"},"jsonld":{"href":"https://registry.alpha.ac/api/public/companies/halozyme-therapeutics-inc?format=jsonld","media_type":"application/ld+json"},"api":{"href":"https://registry.alpha.ac/api/public/companies/halozyme-therapeutics-inc","media_type":"application/json"},"mcp":{"uri":"alpha://companies/halozyme-therapeutics-inc","endpoint":"https://mcp.alpha.ac/mcp","media_type":"application/json"}},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":16,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":7,"distinct_source_count":3,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":16,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":16,"corroborated_claims":0,"sources":7,"distinct_sources":3,"role_claims":0,"last_reviewed_at":"2026-10-05T15:31:01.100054+00:00","observed_at":"2026-10-05T15:31:01.100054+00:00","freshness_days":0}},"claims":[{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:legal_name:1","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"HALOZYME THERAPEUTICS, INC.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"HALOZYME THERAPEUTICS, INC.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/halozyme-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T15:31:01.100054+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:entity_status:3","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/halozyme-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T15:31:01.100054+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:published_fact:4","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/halozyme-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T15:31:01.100054+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:published_fact:5","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:sector","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Healthcare","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Healthcare","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/halozyme-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T15:31:01.100054+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:6","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bernadette-connaughton","object_label":null,"object_source_name_forms":[],"value":"Bernadette Connaughton: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Bernadette Connaughton: Director, Compensation · Chair","corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:document:b3907285327866f69778f0d2143387e5f1c0a0e62778684cbb341ceac3f1ce6b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Halozyme Therapeutics DEF 14A 2026-03-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":"2026-03-23","retrieved_at":"2026-07-12T04:22:07.189599+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-23","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:7","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:matthew-l-posard","object_label":null,"object_source_name_forms":[],"value":"Matthew L. Posard: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Matthew L. Posard: Director, Audit; Nominating and Governance · Chair","corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:document:b3907285327866f69778f0d2143387e5f1c0a0e62778684cbb341ceac3f1ce6b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Halozyme Therapeutics DEF 14A 2026-03-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":"2026-03-23","retrieved_at":"2026-07-12T04:22:07.189599+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-23","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:8","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:cortney-caudill-halo","object_label":null,"object_source_name_forms":[],"value":"Cortney Caudill: Senior Vice President, Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Cortney Caudill: Senior Vice President, Chief Operating Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-17","valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:document:c896607eb5fa02c7a3f3bcf4e4b8769d2792afd74909ef668516e6ace0a89d05","identity_scope":"source_document_reference","source_type":"sec_filing","title":"HALO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm","source_date":"2026-02-17T00:00:00+00:00","retrieved_at":"2026-05-15T02:43:50.405138+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-17T00:00:00+00:00","effective_from":"2026-02-17","effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:9","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:helen-i-torley-halo","object_label":null,"object_source_name_forms":[],"value":"Helen I. Torley: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Helen I. Torley: President, Chief Executive Officer and Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-17","valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:document:06067af1a397d3909dfbe8c738cf81b9a3b580df32a47918d83b4fcdca72df94","identity_scope":"source_document_reference","source_type":"sec_filing","title":"HALO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm","source_date":"2026-02-17T00:00:00+00:00","retrieved_at":"2026-05-15T02:43:49.106918+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-17T00:00:00+00:00","effective_from":"2026-02-17","effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:10","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-snyder-halo","object_label":null,"object_source_name_forms":[],"value":"Mark Snyder: Senior Vice President, General Counsel, Chief Compliance Officer and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Mark Snyder: Senior Vice President, General Counsel, Chief Compliance Officer and Secretary","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-17","valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:document:f3969038db0832d1beab031ff33d2ba5700ff90b9a1781c1333ff4f0ddce1baf","identity_scope":"source_document_reference","source_type":"sec_filing","title":"HALO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm","source_date":"2026-02-17T00:00:00+00:00","retrieved_at":"2026-05-15T02:43:49.965534+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-17T00:00:00+00:00","effective_from":"2026-02-17","effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:11","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:nicole-labrosse-halo","object_label":null,"object_source_name_forms":[],"value":"Nicole LaBrosse: Senior Vice President, Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Nicole LaBrosse: Senior Vice President, Chief Financial Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-17","valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:document:073f0dc17160a9028a5b6e15f06cab340a281b4dfa440621ab690721961a30e3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"HALO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm","source_date":"2026-02-17T00:00:00+00:00","retrieved_at":"2026-05-15T02:43:49.525322+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-17T00:00:00+00:00","effective_from":"2026-02-17","effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_record:12","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair not stated; Members Matthew L. Posard","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":null,"members":[{"display_name":"Matthew L. Posard","person_slug":"matthew-l-posard","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:13","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:matthew-l-posard","object_label":"Matthew L. Posard","object_source_name_forms":[],"value":"Matthew L. Posard: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:matthew-l-posard","name":"Matthew L. Posard"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_record:14","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Bernadette Connaughton; Members Bernadette Connaughton (Chair)","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Bernadette Connaughton","members":[{"display_name":"Bernadette Connaughton","person_slug":"bernadette-connaughton","is_chair":true}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:15","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:bernadette-connaughton","object_label":"Bernadette Connaughton","object_source_name_forms":[],"value":"Bernadette Connaughton: chair, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:bernadette-connaughton","name":"Bernadette Connaughton"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_record:16","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Matthew L. Posard; Members Matthew L. Posard (Chair)","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Matthew L. Posard","members":[{"display_name":"Matthew L. Posard","person_slug":"matthew-l-posard","is_chair":true}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:17","subject_id":"alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:matthew-l-posard","object_label":"Matthew L. Posard","object_source_name_forms":[],"value":"Matthew L. Posard: chair, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:matthew-l-posard","name":"Matthew L. Posard"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T15:31:01.100054+00:00","sources":[{"id":"alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T15:31:01.100054+00:00","reviewed_at":"2026-10-05T15:31:01.100054+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"}],"evidence":[{"id":"alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/halozyme-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T15:31:01.100054+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b3907285327866f69778f0d2143387e5f1c0a0e62778684cbb341ceac3f1ce6b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Halozyme Therapeutics DEF 14A 2026-03-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":"2026-03-23","retrieved_at":"2026-07-12T04:22:07.189599+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c896607eb5fa02c7a3f3bcf4e4b8769d2792afd74909ef668516e6ace0a89d05","identity_scope":"source_document_reference","source_type":"sec_filing","title":"HALO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm","source_date":"2026-02-17T00:00:00+00:00","retrieved_at":"2026-05-15T02:43:50.405138+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:06067af1a397d3909dfbe8c738cf81b9a3b580df32a47918d83b4fcdca72df94","identity_scope":"source_document_reference","source_type":"sec_filing","title":"HALO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm","source_date":"2026-02-17T00:00:00+00:00","retrieved_at":"2026-05-15T02:43:49.106918+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f3969038db0832d1beab031ff33d2ba5700ff90b9a1781c1333ff4f0ddce1baf","identity_scope":"source_document_reference","source_type":"sec_filing","title":"HALO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm","source_date":"2026-02-17T00:00:00+00:00","retrieved_at":"2026-05-15T02:43:49.965534+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:073f0dc17160a9028a5b6e15f06cab340a281b4dfa440621ab690721961a30e3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"HALO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm","source_date":"2026-02-17T00:00:00+00:00","retrieved_at":"2026-05-15T02:43:49.525322+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage":{"identity":"PUBLISHED","business":"PUBLISHED","leadership":"PUBLISHED","board_and_committees":"PUBLISHED","governance":"NOT_ASSERTED","financials":"NOT_ASSERTED","workforce":"NOT_ASSERTED","ownership":"NOT_ASSERTED","ratings":"NOT_PUBLISHED","market_and_index_context":"PUBLISHED"},"representation_version":"alpha-governance-record-v2","role_modules":[],"attention":[],"committee_data":[{"claim_id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:13","payload":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:matthew-l-posard","name":"Matthew L. Posard"},"source_id":"board_seats"}},{"claim_id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:15","payload":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:bernadette-connaughton","name":"Bernadette Connaughton"},"source_id":"board_seats"}},{"claim_id":"alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:17","payload":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:matthew-l-posard","name":"Matthew L. Posard"},"source_id":"board_seats"}}],"quality":{"schema_version":"alpha-record-quality-v1","overall":0.851,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.838,"cross_source_agreement":0.75},"diagnostics":{"published_claims":16,"factual_claims":16,"claims_with_linked_evidence":16,"disputed_claims":0,"stale_claims":0,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"]},"derivation":"deterministic_record_projection"}}